In November 2019, the Danish pharmaceutical company Novo Nordisk controlled almost half of the insulin market in China, in terms of sales volume. Founded in 1923, the firm specializes in producing diabetes medications, which accounted for 80 percent of its annual sales revenue in 2019.
Market share of Novo Nordisk's medication sales in the diabetes care market in China in November 2019, by category
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Novo Nordisk. (February 5, 2020). Market share of Novo Nordisk's medication sales in the diabetes care market in China in November 2019, by category [Graph]. In Statista. Retrieved September 23, 2020, from https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. "Market share of Novo Nordisk's medication sales in the diabetes care market in China in November 2019, by category." Chart. February 5, 2020. Statista. Accessed September 23, 2020. https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. (2020). Market share of Novo Nordisk's medication sales in the diabetes care market in China in November 2019, by category. Statista. Statista Inc.. Accessed: September 23, 2020. https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk. "Market Share of Novo Nordisk's Medication Sales in The Diabetes Care Market in China in November 2019, by Category." Statista, Statista Inc., 5 Feb 2020, https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/
Novo Nordisk, Market share of Novo Nordisk's medication sales in the diabetes care market in China in November 2019, by category Statista, https://www.statista.com/statistics/1122549/china-diabetes-care-market-share-of-novo-nordisk-by-product-type/ (last visited September 23, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
